Stelara (Janssen Biotech, Inc.)


Welcome to the PulseAid listing for the Stelara drug offered from Janssen Biotech, Inc.. This Interleukin-12 Antagonist [EPC],Interleukin-12 Antagonists [MoA],Interleukin-23 Antagonist [EPC],Interleukin-23 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Janssen Biotech, Inc.
NON-PROPRIETARY NAME: ustekinumab
SUBSTANCE NAME: USTEKINUMAB
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Interleukin-12 Antagonist [EPC],Interleukin-12 Antagonists [MoA],Interleukin-23 Antagonist [EPC],Interleukin-23 Antagonists [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2016-09-23
END MARKETING DATE: 0000-00-00


Stelara HUMAN PRESCRIPTION DRUG Details:

Item DescriptionStelara from Janssen Biotech, Inc.
LABELER NAME: Janssen Biotech, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 130(mg/26mL)
START MARKETING DATE: 2016-09-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 57894-054_9864a6b0-c4cd-4c9e-b39b-737172835dd1
PRODUCT NDC: 57894-054
APPLICATION NUMBER: BLA761044

Other USTEKINUMAB Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Janssen Biotech, Inc.Stelara